|
|
Volumn 32, Issue 4, 2012, Pages 36-37
|
|
Reformulations must provide added value: Novel drugs must really improve on the original; dosing convenience alone is not enough
a
a
Veloxis
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ENGINEERING;
GENETIC ENGINEERING;
INDUSTRIAL ENGINEERING;
ADDED VALUES;
BIOTECHNOLOGY;
|
|
EID: 84870361845
PISSN: 1935472X
EISSN: 19378661
Source Type: Journal
DOI: 10.1089/gen.32.4.20 Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
